Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.
Dupuis-Girod S, Ginon I, Saurin JC, Marion D, Guillot E, Decullier E, Roux A, Carette MF, Gilbert-Dussardier B, Hatron PY, Lacombe P, Lorcerie B, Rivière S, Corre R, Giraud S, Bailly S, Paintaud G, Ternant D, Valette PJ, Plauchu H, Faure F.
Dupuis-Girod S, et al. Among authors: ginon i.
JAMA. 2012 Mar 7;307(9):948-55. doi: 10.1001/jama.2012.250.
JAMA. 2012.
PMID: 22396517
Clinical Trial.